Abstract
BackgroundRegulations surrounding clinical trials, manufacturing and commercialization of biosimilars is evolving. Potential barriers to biosimilar adoption in the real-world warrant scrutiny to enable patient access to these medicines.ObjectivesTo assess the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
